EXHIBIT F
SCHEDULE OF TRANSACTIONS EFFECTED DURING THE LAST 60 DAYS
The following table sets forth all transactions with respect to Shares effected in the last sixty (60) days by the Reporting Persons or on behalf of the Reporting Persons in respect of the Shares. The table below includes all transactions through August 23, 2019. All such transactions were sales effected in the open market.
| Transacting Entity |
Trade Date | Buy/Sell | No. of Shares | Price per Share | Security | |||||||||
| New Leaf Ventures III, L.P. |
8/15/2019 | Sell | 71,550 | $ | 36.0911 | (1) | Common Stock | |||||||
| New Leaf Biopharma Opportunities I, L.P. |
8/15/2019 | Sell | 78,450 | $ | 36.0911 | (1) | Common Stock | |||||||
| New Leaf Ventures III, L.P. |
8/16/2019 | Sell | 95,400 | $ | 36.6423 | (2) | Common Stock | |||||||
| New Leaf Biopharma Opportunities I, L.P. |
8/16/2019 | Sell | 104,600 | $ | 36.6423 | (2) | Common Stock | |||||||
| New Leaf Ventures III, L.P. |
8/20/2019 | Sell | 35,775 | $ | 36.8630 | (3) | Common Stock | |||||||
| New Leaf Biopharma Opportunities I, L.P. |
8/20/2019 | Sell | 39,225 | $ | 36.8630 | (3) | Common Stock | |||||||
| New Leaf Ventures III, L.P. |
8/22/2019 | Sell | 40,047 | $ | 36.8513 | (4) | Common Stock | |||||||
| New Leaf Biopharma Opportunities I, L.P. |
8/22/2019 | Sell | 43,910 | $ | 36.8513 | (4) | Common Stock | |||||||
| New Leaf Ventures III, L.P. |
8/23/2019 | Sell | 11,174 | $ | 37.3035 | (5) | Common Stock | |||||||
| New Leaf Biopharma Opportunities I, L.P. |
8/23/2019 | Sell | 12,252 | $ | 37.3035 | (5) | Common Stock | |||||||
| (1) | The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.00 to $36.64, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 1. |
| (2) | The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.00 to $37.32, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 2. |
| (3) | The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.01 to $37.00, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 3. |
| (4) | The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.30 to $37.74, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 4. |
| (5) | The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $37.25 to $37.44, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 5. |